Event Date : 26th JUN at 3:00 PM IST

LIVE WEBINAR

MULTIDRUG RESISTANT Candida auris: SELECTIVE AND DIFFERENTIAL media

LIVE WEBINAR / 26th JUN at 3:00 PM IST / ONLINE

EVENT AGENDA

Candida species are among the top four of nosocomial bloodstream pathogens and cause more than 700,000 invasive infections annually. Therefore, Candida contributes significantly to morbidity and mortality. Non-albicans Candida species are emerging in the nosocomial environment, with the multidrug-resistant (MDR) species Candida auris being the most notorious example. The multi-drug resistant C. auris has been reported to cause cutaneous and invasive infections with high mortality. Indian Council of Medical Research (ICMR) is aware of the numerous outbreaks of C. auris reported globally and from India. Since 2009, the infection has been reported globally from many countries within a short period of time. The yeast is misidentified by common phenotypic automated systems as C. haemulonii, C. famata, C. sake, Saccharomyces cerevisiae, Rhodotorula glutinis, C. lusitaniae, C. guilliermondiior ,C. parapsilosis. Consequently, rapid and accurate species identification has become essential. Definite confirmation of the species can be done by either MALDI-TOF with upgraded database or DNA sequencing, which are not easily available in diagnostic laboratories. There is a need for highly selective and uniquely differentiating media for the presumptive identification of C. auris.

REGISTER NOW

MEET THE SPEAKERS

DR. HARSIMRAN KAUR

ASST. PROF. IN DEPT. OF MEDICAL MICROBIOLOGY AT PGIMER, CHANDIGARH

Lecture on : Need for Selective isolation & identification of multidrug-resistant Candida auris from the clinical samples

Dr. Harsimran Kaur is working in the area of Medical Mycology for the last 6 years. As the faculty of the ‘Centre for Advanced Research’, ‘ WHO collaborating centre for reference and research of fungi of medical importance’ and ‘National culture collection of pathogenic fungi (NCCPF)’, she is involved in diagnostic activities, providing the service of identification of the fungus isolated from clinical samples, providing strains for the research and teaching, maintaining repository of medically important fungi isolated from different part of the country and conducting national level external quality assurance program for mycology.

.

DR. RAHUL G. WARKE

DIRECTOR- R & D MICROBIOLOGY, HIMEDIA LABORATORIES PVT. LTD

Lecture on : Challenges in Chromogenic media development for Candida species.

Dr. Rahul G. Warke has completed his Master’s as well as his doctoral research in Microbiology from Institute of Chemical Technology, Mumbai (ICT- Formerly known as UDCT). Later, he enrolled as researcher in the ‘Biological Warfare’ Programme of the US Navy and continued working with the Department of Cellular Injury, Walter Reed Army Institute of Research, Maryland USA.
During his academic and research tenure, he worked in various aspects of Microbiology. His work on ‘Detection of toxins in Gutka’ received national acclaim and was used as an important reference to introduce regulations within the tobacco industry.

IN ASSOCIATION WITH

LIVE WEBINAR

DR. HARSIMRAN KAUR
DR. RAHUL G. WARKE

26TH JUN 2021, 3:00 PM IST

MICROBIOZ INDIA, THE MAGAZINE
Corp. Office: J3/37,First Floor, DDA Flats Kalka Ji, New Delhi – 110019, India Mob:- +91-9670704431 | Skype:- microbiozindia